T. Miettinen

Type 2 diabetes and treatment intensification in primary care in Finland

L. Niskanen, J. Haukka, P. Vattulainen, 2018, Acta Diabetologica.

Multiple Myeloma Treatments, Outcomes, and Costs of Health Care Resource Utilisation During 2009-2016, Based on Multiple Data Sources from a Hospital District in Finland

J. Jokelainen, M. Bauer, K. Tamminen, 2021, International Journal of Clinical and Experimental Medical Sciences.

Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016

K. Kysenius, P. Anttila, M. Lassenius, 2022, Annals of Hematology.

Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization.

S. Kurki, J. Hahl, T. Miettinen, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

PCN158 PATIENT BURDEN AND COSTS FOR THE TREATMENT OF MULTIPLE MYELOMA IN FINLAND IN 2009-2016, USING MULTIPLE DATA SOURCES: AN ELECTRONIC HOSPITAL DATABASE, MEDICAL CHART REVIEW, AND INTERVIEWS WITH HEALTHCARE PROFESSIONALS

J. Jokelainen, K. Tamminen, J. Salonen, 2019, Value in Health.

Characteristics and survival trends in Finnish multiple myeloma patients—a nationwide real-world evidence study

M. Bauer, P. Anttila, M. Lassenius, 2021, Annals of Hematology.